A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Clinical trial NCT00634270 · COMPLETED

Trial details

NCT number: NCT00634270
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neurofibromatosis Type 1

Start date: 2008-04-01
Primary completion: 2014-11-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.